Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05456321 · ClinicalTrials.gov registry record · NA

CIFASD 5 tDCS and Cognitive Training

A NA study of Fetal Alcohol Spectrum Disorders, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT05456321 is a NA study of Fetal Alcohol Spectrum Disorders that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 70 participants, below the 99-participant average among 10 other Fetal Alcohol Spectrum Disorders trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05456321, a NA study of Fetal Alcohol Spectrum Disorders, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

This is a randomized placebo-controlled trial of cognitive training with transcranial direct current stimulation (tDCS) for children and adolescents (ages 8 - 17 years) with prenatal alcohol exposure (PAE).

Interventions

  • DEVICE Sham tDCS
  • DEVICE Active tDCS
  • BEHAVIORAL Cognitive Training

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2022-11-10
Est. Completion 2027-05-31
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT05456321

The ClinicalTrials.gov registry entry for NCT05456321 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 99-participant average among 10 other Fetal Alcohol Spectrum Disorders trials with a reported enrollment target (29% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fetal Alcohol Spectrum Disorders appearing as the primary indexed condition, and to 3 interventions - of which Sham tDCS is the first listed.

NCT05456321 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05456321 about?

NCT05456321 is a clinical study titled "CIFASD 5 tDCS and Cognitive Training". This is a randomized placebo-controlled trial of cognitive training with transcranial direct current stimulation (tDCS) for children and adolescents (ages 8 - 17 years) with prenatal alcohol exposure (PAE).

What is the current status of trial NCT05456321?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2022-11-10. Estimated completion is 2027-05-31.

What conditions does trial NCT05456321 study?

This clinical trial studies the following conditions: Fetal Alcohol Spectrum Disorders.

What interventions are being tested in trial NCT05456321?

The interventions under investigation include: Sham tDCS (DEVICE), Active tDCS (DEVICE), Cognitive Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05456321?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05456321 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fetal Alcohol Spectrum Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.